Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia (clinicaltrials.gov) - Nov 30, 2023 - P1/2 | N=52 | Active, not recruiting | Sponsor: Center for International Blood and Marrow Transplant Research | Recruiting ➔ Active, not recruiting | N=37 ➔ 52
Enrollment change • Enrollment closed • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
|